IntroductionPatients with end stage renal disease (ESRD) have a higher risk of mortality compared with the general population (Villar et al., 2007). Cardiovascular disease (CVD) is the major cause of mortality in ESRD, and carries a higher risk than the general population (Foley et al., 1998). The development of a risk profile for CVD in ESRD patients has been attempted. Risk factors used as such include: C reactive protein (CRP)